ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,198 | +332.5% | 38,961 | +455.5% | 0.63% | +237.4% |
Q4 2022 | $277 | -99.9% | 7,014 | +10.4% | 0.19% | -72.1% |
Q3 2022 | $255,000 | -1.9% | 6,354 | -5.1% | 0.67% | +185.1% |
Q1 2022 | $260,000 | +381.5% | 6,692 | +507.3% | 0.24% | +279.0% |
Q3 2021 | $54,000 | -81.2% | 1,102 | -80.8% | 0.06% | -80.6% |
Q4 2020 | $287,000 | +277.6% | 5,736 | +214.5% | 0.32% | +315.6% |
Q3 2020 | $76,000 | +40.7% | 1,824 | +65.5% | 0.08% | +285.0% |
Q2 2020 | $54,000 | – | 1,102 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
Brown University | 381,759 | $16,652,000 | 11.44% |
Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |